Aspirin Resistance and Stroke Risk: Platelet Function Analysis in Patients With Ischemic Events

Completed

Phase 2/3 Results

Summary of Purpose

The purpose of this study is to determine if PFA results correlate with ischemic event outcomes as well as bleeding complications. Hypothesis is antiplatelet agents will be more efficacious if they are administered in a dose-adjusted manner using PFA results as a guide.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 2 December 2015.

1 Jul 2007 3 Aug 2011 1 Apr 2010 1 Dec 2011 1 Dec 2015 29 Jun 2015
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Non-Randomized
  • Masking: Open Label
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment

Contacts

Not available